Nutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment

The traditional Mediterranean Diet constitutes a food model that refers to the dietary patterns of the population living in countries bordering the Mediterranean Sea in the early 1960s. A huge volume of literature data suggests that the Mediterranean-style diet provides several dietary compounds that have been reported to exert beneficial biological effects against a wide spectrum of chronic illnesses, such as cardiovascular and neurodegenerative diseases and cancer including breast carcinoma. Among bioactive nutrients identified as protective factors for breast cancer, natural polyphenols, retinoids, and polyunsaturated fatty acids (PUFAs) have been reported to possess antioxidant, anti-inflammatory, immunomodulatory and antitumoral properties. The multiple anticancer mechanisms involved include the modulation of molecular events and signaling pathways associated with cell survival, proliferation, differentiation, migration, angiogenesis, antioxidant enzymes and immune responses. This review summarizes the anticancer action of some polyphenols, like resveratrol and epigallocatechin 3-gallate, retinoids and omega-3 PUFAs by highlighting the important hallmarks of cancer in terms of (i) cell cycle growth arrest, (ii) apoptosis, (iii) inflammation and (iv) angiogenesis. The data collected from in vitro and in vivo studies strongly indicate that these natural compounds could be the prospective candidates for the future anticancer therapeutics in breast cancer disease.

Download Full-text

A Review on Recent Researches of Morinda Citrifolia, L. (Noni) as Functional Foods and Medical Herbs

Jurnal Riset Teknologi Industri ◽

10.26578/jrti.v10i2.2569 ◽

2016 ◽

Vol 10 (2) ◽

pp. 172-186

Author(s):

Agus Sudibyo ◽

Tiurlan F. Hutajulu

Keyword(s):

Vitamin A ◽

Vitamin C ◽

Biological Effects ◽

Morinda Citrifolia ◽

In Vivo Studies ◽

Cancer Disease ◽

Potential Health ◽

Toxicological Assessment

Morinda Citrifolia, L. known as Noni or Mengkudu is planting belonging to the family of Rubiaceae. A number of major components have been identified in leaves, roots, fruits of Noni plant, such as scopoletin, octanoic acid, vitamin C, iridoid, terpenoids, alkaloids, anthraquinones, beta-sitosterol, carotene, vitamin A, flavone glycosides, alizarin, amino acids, acubin, austin, caproic acid, caprylic acid and putative procyonine. Its use as a botanical dietary supplement has grown tremendously in recent years. The results of epidemiological studies suggest that the Noni consumption may help prevent several chronic diseases, including cancer disease, cardiovascular disease, type 2 diabetes mellitus, heart disease, artherosclerosis, blood vessel problem, gastric ulcer, drug addiction, muscle ached and pein. Several studies have also demonstrated anti-inflammatory, antioxidant, antimicrobial, analgesic, and immunologicalactivity. Based on a toxicological assessment, Noni juice was considered as safe. Although, a large number of in vitro and to a certain extent, and in vivo studies demonstrated a range potentially beneficial effects, clinical information data are still lacking completely. Therefore, to what extent the information findings from experimental pharmacological studies is not complete at present, so this article reviews potential health benefits for consumptions, its biological effects and looking for a new informationthat needs to be explored in detail before a recommendation can be madeABSTRAKMorinda citrofolia, L (mengkudu) merupakan jenis tanaman yang termasuk dalam golongan Rubiaceadan buahnya dikenal dengan nama Noni atau mengkudu. Beberapa komponen utama dalam tanaman tersebut telah diidentifikasi, mulai dari bagian akar, daun, dan buah, seperti kandungan scopoletin, asam oktanoad, vitamin C, iridoid, terpenoid, alkaloid, anthraquinon, beta-sitosterol, karotene, vitamin A, flavon glikosida, alizarin, asam amino, acubin, austin, asam kaproat, asam kaprilat dan putativ prokseronin. Buah tersebut akhir-akhir ini telah sukses banyak dimanfaatkan sebagai diet suplemen. Hasil studi secara epidemiologi menyatakan bahwa konsumsi mengkudu dapat membantu mencegah beberapa penyakit kronis, seperti penyakit kanker, kardiovaskular, diabetes tipe 2, penyakit jantung, artherosklerosis, masalah pembuluh darah, pencernaan, dan sakit otot. Beberapa studi juga menunjukkan bahwa mengkudu dapat berfungsi sebagai anti inflamasi, antioksidan, antimikroba, analgesik, dan bersifat immunlogis.Berdasarkan kajian secara toksikologi, buah dan jus mengkudu dinyatakan aman untuk dikonsumsi. Penelitian secara in vitro pada beberapa jenis penyakit tertentu sedang diperluas, dan penelitian secara in vivo menunjukkan bahwa mengkudu mempunyai rentang potensi pengaruh yang baik bagi kesehatan, meskipun data informasinya secara klinis kurang lengkap. Oleh karena itu, untuk mengetahui apa yang sudah ditemukan dari hasil penelitian secara farmalogis yang belum lengkapsaat ini, maka dalam tulisan ini membahas potensi keuntungan kesehatan bila dikonsumsi, pengaruh biologinya dan pencarian informasibaru yang perlu dikaji lebih rinci sebelum rekomendasi ditetapkan.Kata kunci: Mengkudu (Morinda citrifolia, L), pangan fungsional, rempah medis.

Download Full-text

Influence of Olive Oil and Its Components on Breast Cancer: Molecular Mechanisms

Molecules ◽

10.3390/molecules27020477 ◽

2022 ◽

Vol 27 (2) ◽

pp. 477

Author(s):

Raquel Moral ◽

Eduard Escrich

Keyword(s):

Breast Cancer ◽

Olive Oil ◽

Mediterranean Diet ◽

Molecular Mechanisms ◽

Virgin Olive Oil ◽

Extra Virgin Olive Oil ◽

Protective Effects ◽

The Mediterranean

Breast cancer is the most frequent malignant neoplasia and a leading cause of mortality in women worldwide. The Mediterranean diet has been proposed as a healthy dietary pattern with protective effects in several chronic diseases, including breast cancer. This diet is characterized by the consumption of abundant plant foods and olive oil as the principal source of fat, which is considered one of the main components with potential antioxidant, anti-inflammatory and anticancer effects. Extra-virgin olive oil (EVOO) has several bioactive compounds, mainly including monounsaturated fatty acids, triterpenes and polyphenols, such as phenolic alcohols (e.g., hydroxytyrosol), secoiridoids (e.g., oleuropein and oleocanthal), lignans (e.g., pinoresinol) or flavonoids (e.g., luteolin). While epidemiological evidence is still limited, experimental in vivo and in vitro data have shown a protective effect of this oil and its compounds on mammary carcinogenesis. Such effects account through complex and multiple mechanisms, including changes in epigenetics, transcriptome and protein expression that modulate several signaling pathways. Molecular targets of EVOO compounds have a role in the acquisition of cancer hallmarks. Although further research is needed to elucidate their beneficial effects on human prevention and progression of the disease, evidence points to EVOO in the context of the Mediterranean diet as a heathy choice, while EVOO components may be promising adjuvants in anticancer strategies.

Download Full-text

Selective Targeting of Breast Cancer by Tafuramycin a Using SMA-Nanoassemblies

Molecules ◽

10.3390/molecules26123532 ◽

2021 ◽

Vol 26 (12) ◽

pp. 3532

Author(s):

Ibrahim M. El-Deeb ◽

Valeria Pittala ◽

Diab Eltayeb ◽

Khaled Greish

Keyword(s):

Breast Cancer ◽

Progesterone Receptors ◽

In Vivo Studies ◽

Chemotherapy Agent ◽

Anticancer Effects ◽

Tumor Tissues ◽

Potential Strategy ◽

Tumor Accumulation

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of tumors that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. The mainstay of treatment remains chemotherapy, but the therapeutic outcome remains inadequate. This paper investigates the potential of a duocarmycin derivative, tafuramycin A (TFA), as a new and more effective chemotherapy agent in TNBC treatment. To this extent, we optimized the chemical synthesis of TFA, and we encapsulated TFA in a micellar system to reduce side effects and increase tumor accumulation. In vitro and in vivo studies suggest that both TFA and SMA–TFA possess high anticancer effects in TNBC models. Finally, the encapsulation of TFA offered a preferential avenue to tumor accumulation by increasing its concentration at the tumor tissues by around four times in comparison with the free drug. Overall, the results provide a new potential strategy useful for TNBC treatment.

Download Full-text

Modulatory Effects of Osthole on Lipopolysaccharides-Induced Inflammation in Caco-2 Cell Monolayer and Co-Cultures with THP-1 and THP-1-Derived Macrophages

Nutrients ◽

10.3390/nu13010123 ◽

2020 ◽

Vol 13 (1) ◽

pp. 123

Author(s):

Natalia K. Kordulewska ◽

Justyna Topa ◽

Małgorzata Tańska ◽

Anna Cieślińska ◽

Ewa Fiedorowicz ◽

...

Keyword(s):

Gene Expression ◽

Inflammatory Reaction ◽

Wide Spectrum ◽

Cell Monolayer ◽

In Vivo Studies ◽

Dependent Manner ◽

Concentration Dependent Manner ◽

Tnf Α

Lipopolysaccharydes (LPS) are responsible for the intestinal inflammatory reaction, as they may disrupt tight junctions and induce cytokines (CKs) secretion. Osthole has a wide spectrum of pharmacological effects, thus its anti-inflammatory potential in the LPS-treated Caco-2 cell line as well as in Caco-2/THP-1 and Caco-2/macrophages co-cultures was investigated. In brief, Caco-2 cells and co-cultures were incubated with LPS to induce an inflammatory reaction, after which osthole (150–450 ng/mL) was applied to reduce this effect. After 24 h, the level of secreted CKs and changes in gene expression were examined. LPS significantly increased the levels of IL-1β, -6, -8, and TNF-α, while osthole reduced this effect in a concentration-dependent manner, with the most significant decrease when a 450 ng/mL dose was applied (p < 0.0001). A similar trend was observed in changes in gene expression, with the significant osthole efficiency at a concentration of 450 ng/μL for IL1R1 and COX-2 (p < 0.01) and 300 ng/μL for NF-κB (p < 0.001). Osthole increased Caco-2 monolayer permeability, thus if it would ever be considered as a potential drug for minimizing intestinal inflammatory symptoms, its safety should be confirmed in extended in vitro and in vivo studies.

Download Full-text

CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer

Cancers ◽

10.3390/cancers13040898 ◽

2021 ◽

Vol 13 (4) ◽

pp. 898

Author(s):

Ghazal Nabil ◽

Rami Alzhrani ◽

Hashem Alsaab ◽

Mohammed Atef ◽

Samaresh Sau ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

In Vivo Studies ◽

High Dose ◽

Luminal A ◽

Combination Strategy ◽

Ongoing Research

Identified as the second leading cause of cancer-related deaths among American women after lung cancer, breast cancer of all types has been the focus of numerous research studies. Even though triple-negative breast cancer (TNBC) represents 15–20% of the number of breast cancer cases worldwide, its existing therapeutic options are fairly limited. Due to the pivotal role of the presence/absence of specific receptors to luminal A, luminal B, HER-2+, and TNBC in the molecular classification of breast cancer, the lack of these receptors has accounted for the aforementioned limitation. Thereupon, in an attempt to participate in the ongoing research endeavors to overcome such a limitation, the conducted study adopts a combination strategy as a therapeutic paradigm for TNBC, which has proven notable results with respect to both: improving patient outcomes and survivability rates. The study hinges upon an investigation of a promising NPs platform for CD44 mediated theranostic that can be combined with JAK/STAT inhibitors for the treatment of TNBC. The ability of momelotinib (MMB), which is a JAK/STAT inhibitor, to sensitize the TNBC to apoptosis inducer (CFM-4.16) has been evaluated in MDA-MB-231 and MDA-MB-468. MMB + CFM-4.16 combination with a combination index (CI) ≤0.5, has been selected for in vitro and in vivo studies. MMB has been combined with CD44 directed polymeric nanoparticles (PNPs) loaded with CFM-4.16, namely CD44-T-PNPs, which selectively delivered the payload to CD44 overexpressing TNBC with a significant decrease in cell viability associated with a high dose reduction index (DRI). The mechanism underlying their synergism is based on the simultaneous downregulation of P-STAT3 and the up-regulation of CARP-1, which has induced ROS-dependent apoptosis leading to caspase 3/7 elevation, cell shrinkage, DNA damage, and suppressed migration. CD44-T-PNPs showed a remarkable cellular internalization, demonstrated by uptake of a Rhodamine B dye in vitro and S0456 (NIR dye) in vivo. S0456 was conjugated to PNPs to form CD44-T-PNPs/S0456 that simultaneously delivered CFM-4.16 and S0456 parenterally with selective tumor targeting, prolonged circulation, minimized off-target distribution.

Download Full-text

Role of estrogen receptor coregulators in endocrine resistant breast cancer

Exploration of Targeted Anti-tumor Therapy ◽

10.37349/etat.2021.00052 ◽

2021 ◽

pp. 385-400

Author(s):

Kristin A. Altwegg ◽

Ratna K. Vadlamudi

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Therapy Resistance ◽

Vital Role ◽

In Vivo Studies ◽

Scaffolding Proteins ◽

Current State ◽

Er Alpha

Breast cancer (BC) is the most ubiquitous cancer in women. Approximately 70-80% of BC diagnoses are positive for estrogen receptor (ER) alpha (ERα). The steroid hormone estrogen [17β-estradiol (E2)] plays a vital role both in the initiation and progression of BC. The E2-ERα mediated actions involve genomic signaling and non-genomic signaling. The specificity and magnitude of ERα signaling are mediated by interactions between ERα and several coregulator proteins called coactivators or corepressors. Alterations in the levels of coregulators are common during BC progression and they enhance ligand-dependent and ligand-independent ERα signaling which drives BC growth, progression, and endocrine therapy resistance. Many ERα coregulator proteins function as scaffolding proteins and some have intrinsic or associated enzymatic activities, thus the targeting of coregulators for blocking BC progression is a challenging task. Emerging data from in vitro and in vivo studies suggest that targeting coregulators to inhibit BC progression to therapy resistance is feasible. This review explores the current state of ERα coregulator signaling and the utility of targeting the ERα coregulator axis in treating advanced BC.

Download Full-text

Regenerative Therapy and Cancer: In Vitro and In Vivo Studies of the Interaction Between Adipose-Derived Stem Cells and Breast Cancer Cells from Clinical Isolates

Tissue Engineering Part A ◽

10.1089/ten.tea.2010.0248 ◽

2011 ◽

Vol 17 (1-2) ◽

pp. 93-106 ◽

Cited By ~ 146

Author(s):

Ludovic Zimmerlin ◽

Albert D. Donnenberg ◽

J. Peter Rubin ◽

Per Basse ◽

Rodney J. Landreneau ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cells ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Clinical Isolates ◽

In Vivo Studies ◽

Adipose Derived Stem Cells ◽

Regenerative Therapy

Download Full-text

Analysis on Homoeopathic Preparation of Asterias Rubens for Evaluating Anti Breast Cancer Cell Line using Similia Principle

International Journal of Research in Pharmaceutical Sciences ◽

10.26452/ijrps.v11ispl4.4075 ◽

2020 ◽

Vol 11 (SPL4) ◽

pp. 805-808

Author(s):

Ravikumar Raju ◽

Teja ◽

Sravanathi P ◽

Muthu Babu K

Keyword(s):

Breast Cancer ◽

Cell Line ◽

Cancer Cell ◽

Cancer Cell Line ◽

In Vitro Study ◽

In Vivo Studies ◽

Asterias Rubens ◽

Mcf 7

Breast cancer is the subsequent foremost reason of cancer death in a woman and ranks as the primary foremost reason of death in India. In its conduct, several measures and recommendation are considered. Homoeopathic medicines are one of the part of a corresponding, and another medicine is utilized for the treatment of cancer. The main purpose of the investigation is to evaluate the anticancer action of homoeopathic arrangements of Asterias rubens on the basis of the similia principle. We directed an in vitro study using MTT assay to control the result of ultra diluted homoeopathic preparation in contradiction of two human breast glandular cancer cell lines(MCF-7 and MDA-MD- 231), frequently used for the breast cancer treatment, by testing the feasibility of breast cancer (MCF-7 and MDA-MD-231) cell line, with various attenuations of Asterias rubens at 24 hrs. Multiple comparisons between tested reagents at different concentrations confirmed the significance of the said results. At a dilution of 1:25 6CH and 30CH potency shown superior activity on MCF-7 and no such significant changes on MDA-MD-231 at any dilutions As it fails to offer estrogen receptor(ER) Also progesterone receptor (PR) expression, and also HER2 (human epidermal development variable receptor2) so continuously a triple-negative breast cancer it will be a hostility manifestation for breast cancer with restricted medicine choices. However, further potency needs to be tested. These preliminary significant results warrant further in vitro and in vivo studies to estimate the possible of Asterias rubens a medicine to treat breast cancer.

Download Full-text

Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence

Biomolecules ◽

10.3390/biom9120777 ◽

2019 ◽

Vol 9 (12) ◽

pp. 777 ◽

Cited By ~ 1

Author(s):

Javad Sharifi-Rad ◽

Farzad Kobarfard ◽

Athar Ata ◽

Seyed Abdulmajid Ayatollahi ◽

Nafiseh Khosravi-Dehaghi ◽

...

Keyword(s):

Chemical Composition ◽

Clinical Studies ◽

Positive Impact ◽

Biological Effects ◽

Food Supplement ◽

In Vivo Studies ◽

Plant Chemical ◽

Food Applications

Members of the Prosopis genus are native to America, Africa and Asia, and have long been used in traditional medicine. The Prosopis species most commonly used for medicinal purposes are P. africana, P. alba, P. cineraria, P. farcta, P. glandulosa, P. juliflora, P. nigra, P. ruscifolia and P. spicigera, which are highly effective in asthma, birth/postpartum pains, callouses, conjunctivitis, diabetes, diarrhea, expectorant, fever, flu, lactation, liver infection, malaria, otitis, pains, pediculosis, rheumatism, scabies, skin inflammations, spasm, stomach ache, bladder and pancreas stone removal. Flour, syrup, and beverages from Prosopis pods have also been potentially used for foods and food supplement formulation in many regions of the world. In addition, various in vitro and in vivo studies have revealed interesting antiplasmodial, antipyretic, anti-inflammatory, antimicrobial, anticancer, antidiabetic and wound healing effects. The phytochemical composition of Prosopis plants, namely their content of C-glycosyl flavones (such as schaftoside, isoschaftoside, vicenin II, vitexin and isovitexin) has been increasingly correlated with the observed biological effects. Thus, given the literature reports, Prosopis plants have positive impact on the human diet and general health. In this sense, the present review provides an in-depth overview of the literature data regarding Prosopis plants’ chemical composition, pharmacological and food applications, covering from pre-clinical data to upcoming clinical studies.

Download Full-text